1.1 	A bill for an act
1.2 	relating to human services; modifying certain provisions governing autism early 
1.3 	intensive intervention benefit;amending Minnesota Statutes 2016, section 
1.4 	256B.0949.
1.5 	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

1.6 	Section 1. Minnesota Statutes 2016, section 256B.0949, is amended to read:
1.7 	256B.0949 ~~AUTISM~~ EARLY INTENSIVE DEVELOPMENTAL AND 
1.8 	BEHAVIORAL INTERVENTION BENEFIT.
1.9 		Subdivision 1.Purpose. This section ~~creates a new benefit~~ authorizes the early intensive 
1.10 	developmental and behavioral intervention (EIDBI) benefit to provide early intensive 
1.11 	intervention to a ~~child~~ person with an autism spectrum disorder ~~diagnosis~~ or a related 
1.12 	condition. This benefit must provide coverage for ~~diagnosis~~ a comprehensive, 
1.13 	multidisciplinary ~~assessment~~ evaluation, ongoing progress evaluation, and medically 
1.14 	necessary early intensive treatment of autism spectrum disorder or a related condition.
1.15 		Subd. 2.Definitions. (a) ~~For the purposes of this section,~~ The terms ~~defined~~ used in this 
1.16 	~~subdivision~~ section have the meanings given in this subdivision.
1.17 	~~(b) "Autism spectrum disorder diagnosis" is defined by diagnostic code 299 in the current~~ 
1.18 	~~version of the Diagnostic and Statistical Manual of Mental Disorders (DSM).~~
1.19 	(b) "Agency" means the legal entity that is enrolled with Minnesota health care programs 
1.20 	as a medical assistance provider according to Minnesota Rules, part 9505.0195, to provide 
1.21 	EIDBI services and that has the legal responsibility to ensure that its employees or contractors 
1.22 	carry out the responsibilities defined in this section. Agency includes a licensed individual 
1.23 	professional who practices independently and acts as an agency.
2.1 	(c) "Autism spectrum disorder or a related condition" or "ASD or a related condition" 
2.2 	means either autism spectrum disorder (ASD) as defined in the current version of the 
2.3 	Diagnostic and Statistical Manual of Mental Disorders (DSM) or a condition that is found 
2.4 	to be closely related to ASD, as identified under the current version of the DSM, and meets 
2.5 	all of the following criteria:
2.6 	(1) is severe and chronic;
2.7 	(2) results in impairment of adaptive behavior and function similar to that of a person 
2.8 	with ASD;
2.9 	(3) requires treatment or services similar to those required for a person with ASD; and
2.10 	(4) results in substantial functional limitations in three core developmental deficits of 
2.11 	ASD: social interaction; nonverbal or social communication; and restrictive, repetitive 
2.12 	behaviors or hyperreactivity or hyporeactivity to sensory input; and may include deficits or 
2.13 	a high level of support in one or more of the following domains:
2.14 	(i) self-regulation;
2.15 	(ii) self-care;
2.16 	(iii) behavioral challenges;
2.17 	(iv) expressive communication;
2.18 	(v) receptive communication;
2.19 	(vi) cognitive functioning; or
2.20 	(vii) safety.
2.21 	~~(c)~~ (e) "~~Child~~ Person" means a person under ~~the age of 18~~ 21 years of age.
2.22 	(f) "Clinical supervision" means the overall responsibility for the control and direction 
2.23 	of EIDBI service delivery, including individual treatment planning, staff supervision, 
2.24 	individual treatment plan progress monitoring, and treatment review for each person. Clinical 
2.25 	supervision is provided by a qualified supervising professional (QSP) who takes full 
2.26 	professional responsibility for the service provided by each supervisee.
2.27 	~~(d)~~ (g) "Commissioner" means the commissioner of human services, unless otherwise 
2.28 	specified.
2.29 	(h) "Comprehensive multidisciplinary evaluation" or "CMDE" means a comprehensive 
2.30 	evaluation of a person to determine medical necessity for EIDBI services based on the 
2.31 	requirements in subdivision 5.
3.1 	(i) "Department" means the Department of Human Services, unless otherwise specified.
3.2 	~~(e)~~ (j) "Early intensive developmental and behavioral intervention benefit" or "EIDBI 
3.3 	benefit" means ~~autism treatment options~~ a variety of individualized, intensive treatment 
3.4 	modalities approved by the commissioner that are based in behavioral and developmental 
3.5 	science~~, which may include modalities such as applied behavior analysis, developmental~~ 
3.6 	~~treatment approaches, and naturalistic and parent training models~~ consistent with best 
3.7 	practices on effectiveness.
3.8 	~~(f)~~ (k) "Generalizable goals" means results or gains that are observed during a variety 
3.9 	of activities over time with different people, such as providers, family members, other adults, 
3.10 	and ~~children~~ people, and in different environments including, but not limited to, clinics, 
3.11 	homes, schools, and the community.
3.12 	(l) "Incident" means when any of the following occur:
3.13 	(1) an illness, accident, or injury that requires first aid treatment;
3.14 	(2) a bump or blow to the head; or
3.15 	(3) an unusual or unexpected event that jeopardizes the safety of a person or staff, 
3.16 	including a person leaving the agency unattended.
3.17 	(m) "Individual treatment plan" or "ITP" means the person-centered, individualized 
3.18 	written plan of care that integrates and coordinates person and family information from the 
3.19 	CMDE for a person who meets medical necessity for the EIDBI benefit. An individual 
3.20 	treatment plan must meet the standards in subdivision 6.
3.21 	(n) "Legal representative" means the parent of a child who is under 18 years of age, a 
3.22 	court-appointed guardian, or other representative with legal authority to make decisions 
3.23 	about service for a person. For the purpose of this subdivision, "other representative with 
3.24 	legal authority to make decisions" includes a health care agent or an attorney-in-fact 
3.25 	authorized through a health care directive or power of attorney.
3.26 	~~(g)~~ (o) "Mental health professional" has the meaning given in section 245.4871, 
3.27 	subdivision 27, clauses (1) to (6).
3.28 	(p) "Person-centered" means a service that both responds to the identified needs, interests, 
3.29 	values, preferences, and desired outcomes of the person or the person's legal representative 
3.30 	and  respects the person's history, dignity, and cultural background and allows inclusion and 
3.31 	participation in the person's community.
4.1 	(q) "Qualified EIDBI provider" means a person who is a QSP or a level I, level II, or 
4.2 	level III treatment provider.
4.3 		Subd. 3.~~Initial~~ EIDBI eligibility. ~~This benefit~~ An EIDBI service is available to a ~~child~~
4.4 	person enrolled in medical assistance who:
4.5 	(1) has ~~an autism spectrum disorder~~ a diagnosis of ASD or a related condition that meets 
4.6 	the criteria of subdivision 4; and
4.7 	~~(2) has had a diagnostic assessment described in subdivision 5, which recommends early~~ 
4.8 	~~intensive intervention services; and~~
4.9 	~~(3)~~ (2) meets the criteria for medically necessary ~~autism early intensive intervention~~ 
4.10 	~~services~~ for the EIDBI benefit.
4.11 		Subd. 3a.Culturally and linguistically appropriate requirement. The person's and 
4.12 	family's primary spoken language and culture, values, goals, and preferences must be 
4.13 	reflected throughout the covered services. The CMDE provider and QSP must determine 
4.14 	how to adapt the evaluation, treatment recommendations, and individual treatment plan to 
4.15 	the person's and family's culture, values, and language preferences. A provider must have 
4.16 	a limited English proficiency (LEP) plan in compliance with title VI of the Civil Rights Act 
4.17 	of 1964, United States Code, title 42, section 2000d to 2000d-7.
4.18 		Subd. 4.Diagnosis. (a) A diagnosis of ASD or a related condition must:
4.19 	(1) be based upon current DSM criteria including direct observations of the ~~child~~ person
4.20 	and ~~reports~~ information from ~~parents~~ the person's legal representative or primary caregivers; 
4.21 	~~and~~
4.22 	(2) be completed by either (i) a licensed physician or advanced practice registered nurse 
4.23 	or (ii) a mental health professional; and
4.24 	(3) meet the requirements of Minnesota Rules, part 9505.0372, subpart 1, items B and 
4.25 	C.
4.26 	(b) Additional ~~diagnostic~~ assessment information may be considered to complete a 
4.27 	diagnostic assessment including ~~from~~ specialized tests administered through special education 
4.28 	evaluations and licensed school personnel, and from professionals licensed in the fields of 
4.29 	medicine, speech and language, psychology, occupational therapy, and physical therapy.
4.30 	A diagnostic assessment may include treatment recommendations.
4.31 		Subd. 5.~~Diagnostic assessment~~ Comprehensive multidisciplinary evaluation. ~~The~~ 
4.32 	~~following~~ (a) A CMDE must be completed to determine medical necessity of EIDBI services. 
5.1 	For the commissioner to authorize EIDBI services, the CMDE provider must submit the 
5.2 	CMDE to the commissioner and the person or the person's legal representative as determined 
5.3 	by the commissioner. Information and assessments must be performed, reviewed, and relied 
5.4 	upon for the eligibility determination, treatment and services recommendations, and treatment 
5.5 	plan development for the ~~child:~~ person.
5.6 	(b) The CMDE must:
5.7 	(1) include an assessment of the ~~child's~~ person's developmental skills, functional behavior, 
5.8 	needs, and capacities based on direct observation of the ~~child~~ person which must be 
5.9 	administered by a ~~licensed mental health professional~~ CMDE provider, ~~must~~ include medical 
5.10 	or assessment information from the ~~child's~~ person's physician or advanced practice registered 
5.11 	nurse, and may also include ~~observations~~ input from family members, school personnel, 
5.12 	child care providers, or other caregivers, as well as any medical or assessment information 
5.13 	from other licensed professionals such as rehabilitation or habilitation therapists, licensed 
5.14 	school personnel, or mental health professionals; ~~and~~
5.15 	~~(2) an assessment of parental or caregiver capacity to participate in therapy including~~ 
5.16 	~~the type and level of parental or caregiver involvement and training recommended.~~
5.17 	(2) include and document the person's legal representative's or primary caregiver's 
5.18 	preferences for involvement in the person's treatment; and
5.19 	(3) provide information about the range of current EIDBI treatment modalities recognized 
5.20 	by the commissioner.
5.21 		Subd. 5a.Comprehensive multidisciplinary evaluation provider qualification. A 
5.22 	CMDE provider must:
5.23 	(1) be a licensed physician, advanced practice registered nurse, a mental health 
5.24 	professional, or a mental health practitioner who meets the requirements of a clinical trainee 
5.25 	as defined in Minnesota Rules, part 9505.0371, subpart 5, item C;
5.26 	(2) have at least 2,000 hours of clinical experience in the evaluation and treatment of 
5.27 	people with ASD or a related condition or equivalent documented coursework at the graduate 
5.28 	level by an accredited university in the following content areas: ASD or a related condition 
5.29 	diagnosis, ASD or a related condition treatment strategies, and child development; and
5.30 	(3) be able to diagnose, evaluate, or provide treatment within the provider's scope of 
5.31 	practice and professional license.
5.32 		Subd. 6.Individual treatment plan. (a) The QSP, level I treatment provider, or level 
5.33 	II treatment provider who integrates and coordinates person and family information from 
6.1 	the CMDE and ITP progress monitoring process to develop the ITP must develop and 
6.2 	monitor the ITP.
6.3 	(b) Each ~~child's treatment plan~~ person's ITP must be:
6.4 	(1) culturally and linguistically appropriate, as required under subdivision 3a, 
6.5 	individualized, and person-centered; and
6.6 	~~(1)~~ (2) based on the ~~diagnostic assessment~~ diagnosis and CMDE information specified 
6.7 	in subdivisions 4 and 5~~;~~.
6.8 	~~(2) coordinated with medically necessary occupational, physical, and speech and language~~ 
6.9 	~~therapies, special education, and other services the child and family are receiving;~~
6.10 	~~(3) family-centered;~~
6.11 	~~(4) culturally sensitive; and~~
6.12 	~~(5) individualized based on the child's developmental status and the child's and family's~~ 
6.13 	~~identified needs.~~
6.14 	~~(b)~~ (c) The ~~treatment plan~~ ITP must specify ~~the~~:
6.15 	~~(1) child's goals which are developmentally appropriate, functional, and generalizable;~~
6.16 	~~(2) treatment modality;~~
6.17 	~~(3) treatment intensity;~~
6.18 	~~(4) setting; and~~
6.19 	~~(5) level and type of parental or caregiver involvement.~~
6.20 	(1) the medically necessary treatment and service;
6.21 	(2) the treatment modality that shall be used to meet the goals and objectives, including:
6.22 	(i) baseline measures and projected dates of accomplishment;
6.23 	(ii) the frequency, intensity, location, and duration of each service provided;
6.24 	(iii) the level of legal representative or primary caregiver training and counseling;
6.25 	(iv) any change or modification to the physical and social environments necessary to 
6.26 	provide a service;
6.27 	(v) significant changes in the person's condition or family circumstance;
6.28 	(vi) any specialized equipment or material required;
7.1 	(vii) techniques that support and are consistent with the person's communication mode 
7.2 	and learning style;
7.3 	(viii) the name of the QSP; and
7.4 	(ix) progress evaluation results and goal mastery data; and
7.5 	(3) the discharge criteria that shall be used and a defined transition plan that meets the 
7.6 	requirement of paragraph (g).
7.7 	~~(c)~~ (d) Implementation of the ~~treatment~~ ITP must be supervised by a ~~professional with~~ 
7.8 	~~expertise and training in autism and child development who is a licensed physician, advanced~~ 
7.9 	~~practice registered nurse, or mental health professional~~ QSP.
7.10 	~~(d)~~ (e) The ~~treatment plan~~ ITP must be submitted to the commissioner and the person 
7.11 	or the person's legal representative for approval in a manner determined by the commissioner 
7.12 	for this purpose.
7.13 	~~(e) Services authorized must be consistent with the child's approved treatment plan.~~
7.14 	(f) ~~Services~~ A service included in the ~~treatment plan~~ ITP must meet all applicable 
7.15 	requirements for medical necessity and coverage.
7.16 	(g) To terminate service, the provider must send notice of termination to the person or 
7.17 	the person's legal representative. The transition period begins when the person or the person's 
7.18 	legal representative receives notice of termination from the EIDBI service and ends when 
7.19 	the EIDBI service is terminated. Up to 30 days of continued service is allowed during the 
7.20 	transition period. Services during the transition period shall be consistent with the ITP. The 
7.21 	transition plan shall include:
7.22 	(1) protocols for changing service when medically necessary;
7.23 	(2) how the transition will occur;
7.24 	(3) the time allowed to make the transition; and
7.25 	(4) a description of how the person or the person's legal representative will be informed 
7.26 	of and involved in the transition.
7.27 		Subd. 7.~~Ongoing eligibility~~ Individualized treatment plan progress monitoring. (a) 
7.28 	An ~~independent~~ ITP progress evaluation ~~conducted by a licensed mental health professional~~ 
7.29 	~~with expertise and training in autism spectrum disorder and child development~~ must be 
7.30 	~~completed~~ submitted after each six months of treatment, or more frequently as determined 
7.31 	by the ~~commissioner~~ CMDE provider or QSP, to determine if progress is being made toward 
7.32 	~~achieving~~ targeted functional and generalizable goals ~~and meeting functional goals contained~~
8.1 	specified in the ~~treatment plan~~ ITP. Based on the results of ITP progress monitoring, the 
8.2 	ITP must be adjusted as needed and must document that the EIDBI service continues to be 
8.3 	medically necessary for the person or the person is referred to other services.
8.4 	(b) The ITP progress evaluation must include:
8.5 	~~(1) the treating provider's report;~~
8.6 	~~(2) parental or caregiver~~ (1) input from the person's legal representative or the person's 
8.7 	primary caregiver;
8.8 	~~(3)~~ (2) an ~~independent~~ observation of the ~~child which can be~~ person that is performed 
8.9 	by ~~the child's~~ the QSP, level I treatment provider, or level II treatment provider and may 
8.10 	include input from licensed special education staff or other licensed health care provider;
8.11 	(3) documentation of the person's current level of performance on primary treatment 
8.12 	goal domains including when a goal or objective is achieved, changed, or discontinued;
8.13 	(4) any significant change in the person's condition or family circumstances;
8.14 	~~(4)~~ (5) any treatment plan ~~modifications~~ modification and the rationale for any change 
8.15 	made, including treatment modality, intensity, frequency, and duration; and
8.16 	~~(5)~~ (6) recommendations for continued treatment ~~services~~.
8.17 	(c) The ITP progress ~~evaluations~~ monitoring must be submitted to the commissioner ~~in~~ 
8.18 	~~a manner~~ and the person or the person's legal representative in a manner determined by the 
8.19 	commissioner for ~~this purpose~~ the reauthorization of EIDBI services.
8.20 	(d) A ~~child~~ person who continues to ~~achieve generalizable goals and~~ make reasonable 
8.21 	progress toward treatment goals as specified in the ~~treatment plan~~ ITP is eligible to continue 
8.22 	receiving ~~this benefit~~ EIDBI services.
8.23 	(e) A ~~child's~~ person's treatment shall continue during the ITP progress ~~evaluation~~
8.24 	monitoring using the process determined under ~~subdivision 8, clause (8)~~ this subdivision. 
8.25 	Treatment may continue during an appeal pursuant to section 256.045.
8.26 		Subd. 8.Refining the benefit with stakeholders. The commissioner must ~~develop the~~ 
8.27 	~~implementation~~ refine the details of the benefit in consultation with stakeholders and consider 
8.28 	recommendations from ~~the Health Services Advisory Council,~~ the Department of Human 
8.29 	Services ~~Autism Spectrum Disorder~~ Early Intensive Developmental and Behavioral 
8.30 	Intervention Advisory Council, the ~~Legislative Autism Spectrum Disorder Task Force~~ early 
8.31 	intensive developmental and behavioral intervention learning collaborative, and the 
8.32 	~~Interagency Task Force of the~~ Departments of Health, Education, Employment and Economic 
9.1 	Development,  and Human Services. ~~The commissioner must release these details for a~~ 
9.2 	~~30-day public comment period prior to submission to the federal government for approval.~~
9.3 	The ~~implementation~~ details must include, but are not limited to, the following components:
9.4 	(1) a definition of the qualifications, standards, and roles of the treatment team, including 
9.5 	recommendations after stakeholder consultation on whether board-certified behavior analysts 
9.6 	and other ~~types of~~ professionals certified in other treatment approaches recognized by the 
9.7 	department or  trained in ~~autism spectrum disorder~~ ASD or a related condition and child 
9.8 	development should be added as ~~mental health or other~~ professionals ~~for treatment~~ qualified 
9.9 	to provide EIDBI clinical supervision or other functions under medical assistance;
9.10 	(2) ~~development of initial,~~ refinement of uniform parameters for ~~comprehensive~~ 
9.11 	~~multidisciplinary diagnostic assessment information~~ CMDE and ~~progress evaluation~~ ongoing 
9.12 	ITP progress evaluation standards;
9.13 	(3) the design of an effective and consistent process for assessing ~~parent~~ the person's 
9.14 	and the person's legal representative's  and ~~caregiver capacity~~ the person's caregiver's 
9.15 	preferences and options to participate in the ~~child's~~ person's early intervention treatment 
9.16 	and efficacy of methods ~~of involving the parents~~ to involve and educate the person's legal 
9.17 	representative and ~~caregivers~~ caregiver in the treatment of the ~~child~~ person;
9.18 	(4) formulation of a collaborative process in which professionals have opportunities to 
9.19 	collectively inform ~~a comprehensive, multidisciplinary diagnostic assessment~~provider 
9.20 	standards and qualifications; standards for CMDE; medical necessity determination; efficacy 
9.21 	of treatment apparatus, including modality, intensity, frequency, and duration; and ~~progress~~ 
9.22 	~~evaluation~~ ITP progress evaluation processes ~~and standards~~ to support quality improvement 
9.23 	of ~~early intensive intervention~~ EIDBI services;
9.24 	(5) coordination of this benefit and its interaction with other services provided by the 
9.25 	Departments of Human Services, Health, Employment and Economic Development, and 
9.26 	Education;
9.27 	(6) evaluation, on an ongoing basis, of ~~research regarding the program~~ EIDBI services 
9.28 	outcomes and efficacy of treatment modalities provided to ~~children~~ people under this benefit;
9.29 	and
9.30 	(7) as provided under subdivision 17, determination of the availability of ~~licensed~~ 
9.31 	~~physicians, nurse practitioners, and mental health professionals~~ qualified EIDBI providers
9.32 	with necessary expertise and training in ~~autism spectrum disorder~~ ASD or a related condition
9.33 	throughout the state to assess whether there are sufficient professionals ~~to require involvement~~ 
9.34 	~~of both a physician or nurse practitioner and a mental health professional~~ to provide timely
10.1 	access and prevent delay in the ~~diagnosis~~ CMDE and treatment of ~~young children, so as to~~ 
10.2 	~~implement subdivision 4, and to ensure treatment is effective, timely, and accessible; and~~
10.3 	a person with ASD or a related condition.
10.4 	~~(8) development of the process for the progress evaluation that will be used to determine~~ 
10.5 	~~the ongoing eligibility, including necessary documentation, timelines, and responsibilities~~ 
10.6 	~~of all parties.~~
10.7 		Subd. 9.Revision of treatment options. (a) The commissioner may revise covered 
10.8 	treatment options as needed based on outcome data and other evidence. EIDBI treatment 
10.9 	modalities approved by the department must:
10.10 	(1) cause no harm to the person or the person's family;
10.11 	(2) be individualized and person-centered;
10.12 	(3) be developmentally appropriate and highly structured, with well-defined goals and 
10.13 	objectives that provide a strategic direction for treatment;
10.14 	(4) be based in recognized principles of developmental and behavioral science;
10.15 	(5) utilize sound practices that are replicable across providers and maintain the fidelity 
10.16 	of the specific modality;
10.17 	(6) demonstrate an evidentiary basis;
10.18 	(7) have goals and objectives that are measurable, achievable, and be regularly evaluated 
10.19 	and adjusted to ensure that adequate progress is being made;
10.20 	(8) be provided intensively with a high staff-to-person ratio; and
10.21 	(9) include participation by the person and the person's legal representative in decision 
10.22 	making, knowledge building and capacity building, and developing and implementing the 
10.23 	person's ITP.
10.24 	(b) Before ~~the changes~~ revisions in department recognized treatment modalities become 
10.25 	effective, the commissioner must provide public notice of the changes, the reasons for the 
10.26 	change, and a 30-day public comment period to those who request notice through an 
10.27 	electronic list accessible to the public on the department's Web site.
10.28 		Subd. 10.Coordination between agencies and other benefits. (a) The commissioners 
10.29 	of human services and education must develop the capacity to coordinate services and 
10.30 	information including diagnostic, functional, developmental, medical, and educational 
10.31 	assessments; service delivery; and progress evaluations across health and education sectors.
11.1 	(b) An EIDBI service provided under this section is not intended to replace a service 
11.2 	provided in school or other settings. A person's ITP must document that EIDBI services 
11.3 	coordinate with, but do not include or replace, special education and related services defined 
11.4 	in the person's individualized education plan (IEP), or individualized family service plan 
11.5 	(IFSP), when the service is available under the Individuals with Disabilities Education 
11.6 	Improvement Act of 2004, United States Code, title 20, chapter 33, through a local education 
11.7 	agency. This provision does not preclude EIDBI treatment during school hours. A program 
11.8 	for birth to three years of age and additional resources must also coordinate with EIDBI 
11.9 	services. A resource for a person over 18 years of age must also be coordinated with EIDBI 
11.10 	services under this section.
11.11 	(c) The commissioner shall integrate medical authorization procedures for an EIDBI 
11.12 	service with authorization procedures for other health and mental health services and home 
11.13 	and community-based services to ensure that the person receives services that are the most 
11.14 	appropriate and effective in meeting the person's needs.
11.15 		Subd. 11.Federal approval of the ~~autism~~ EIDBI benefit. (a) This section shall apply 
11.16 	to state plan services under title XIX of the Social Security Act when federal approval is 
11.17 	granted under a 1915(i) waiver or other authority which allows children eligible for medical 
11.18 	assistance through the TEFRA option under section 256B.055, subdivision 12, to qualify 
11.19 	and includes children eligible for medical assistance in families over 150 percent of the 
11.20 	federal poverty guidelines.
11.21 	(b) The commissioner may use the federal authority for a Medicaid state plan amendment 
11.22 	under Early and Periodic Screening Diagnosis and Treatment (EPSDT), United States Code, 
11.23 	title 42, section 1396D(R)(5), or other Medicaid provision for any aspect or type of treatment 
11.24 	covered in this section if new federal guidance is helpful in achieving one or more of the 
11.25 	purposes of this section in a cost-effective manner. Notwithstanding subdivisions 2 and 3, 
11.26 	any treatment services submitted for federal approval under EPSDT shall include appropriate 
11.27 	medical criteria to qualify for the service and shall cover children through ~~age~~ 20 years of 
11.28 	age.
11.29 		Subd. 12.~~Autism~~ EIDBI benefit; training provided. After approval of the ~~autism early~~ 
11.30 	~~intensive intervention~~ EIDBI benefit under this section by the Centers for Medicare and 
11.31 	Medicaid Services, the commissioner shall provide statewide training on the benefit for 
11.32 	culturally and linguistically diverse communities. Training for ~~autism service~~ EIDBI
11.33 	providers on culturally appropriate practices must be online, accessible, and available in 
11.34 	multiple languages. The training for families, lead agencies, advocates, and other interested 
11.35 	parties must provide information about the EIDBI benefit and how to access it.
12.1 		Subd. 13.Covered services. (a) The services described in paragraphs (b) to (i) are 
12.2 	eligible for reimbursement by medical assistance under this section. Services must be 
12.3 	provided by a qualified EIDBI provider and supervised by a QSP. An EIDBI service must 
12.4 	address the person's medically necessary treatment goals and must be targeted to develop, 
12.5 	enhance, or maintain the individual developmental skills of a person with ASD or a related 
12.6 	condition to improve functional communication, social or interpersonal interaction, behavioral 
12.7 	challenges and self-regulation, cognition, learning and play, self-care, safety, and level of 
12.8 	support needed.
12.9 	(b) EIDBI modalities include, but are not limited to:
12.10 	(1) applied behavior analysis (ABA);
12.11 	(2) developmental individual-difference relationship-based model (DIR/Floortime);
12.12 	(3) early start Denver model (ESDM);
12.13 	(4) PLAY project; or
12.14 	(5) relationship development intervention (RDI).
12.15 	(c) An EIDBI provider may use one or more of the EIDBI modalities in paragraph (b), 
12.16 	clauses (1) to (5), as the primary modality for treatment as a covered service, or several 
12.17 	EIDBI modalities in combination as the primary modality of treatment, as approved by the 
12.18 	commissioner. An EIDBI provider that identifies and provides assurance of qualifications 
12.19 	for a single specific treatment modality must document the required qualifications to meet 
12.20 	fidelity to the specific model. Additional EIDBI modalities not listed in paragraph (b) may 
12.21 	be covered upon approval by the commissioner.
12.22 	(d) CMDE is a comprehensive evaluation of the person's developmental status to 
12.23 	determine medical necessity for EIDBI services and meets the requirements of subdivision 
12.24 	5. The services must be provided by a qualified CMDE provider.
12.25 	(e) EIDBI intervention observation and direction is the clinical direction and oversight 
12.26 	of EIDBI services by the QSP, level I treatment provider, or level II treatment provider, 
12.27 	including developmental and behavioral techniques, progress measurement, data collection, 
12.28 	function of behaviors, and generalization of acquired skills for the direct benefit of a person. 
12.29 	EIDBI intervention observation and direction informs any modification of the methods to 
12.30 	support the outcomes in the ITP. EIDBI intervention observation and direction provides a 
12.31 	real-time response to EIDBI interventions to maximize the benefit to the person.
12.32 	(f) ITP development and ITP progress monitoring is development of the initial, annual, 
12.33 	and progress monitoring of an ITP. ITP development and ITP progress monitoring 
13.1 	documents, provides oversight and ongoing evaluation of a person's treatment and progress 
13.2 	on targeted goals and objectives, and integrates and coordinates the person's and the person's 
13.3 	legal representative's information from the CMDE and ITP progress monitoring. This service 
13.4 	must be reviewed and completed by the QSP, and may include input from a level I treatment 
13.5 	provider or a level II treatment provider.
13.6 	(g) Family caregiver training and counseling is specialized training and education for a 
13.7 	family or primary caregiver to understand the person's developmental status and help with 
13.8 	the person's needs and development. This service must be provided by the QSP, level I 
13.9 	treatment provider, or level II treatment provider.
13.10 	(h) A coordinated care conference is a voluntary face-to-face meeting with the person 
13.11 	and the person's family to review the CMDE or ITP progress evaluation and to integrate 
13.12 	and coordinate services across providers and service-delivery systems to develop the ITP. 
13.13 	This service must be provided by the QSP and may include the CMDE provider or a level 
13.14 	I treatment provider or a level II treatment provider.
13.15 	(i) Travel time is allowable billing for traveling to and from the person's home, school, 
13.16 	a community setting, or place of service outside of an EIDBI center, clinic, or office from 
13.17 	a specified location to provide face-to-face EIDBI intervention, observation and direction, 
13.18 	or family caregiver training and counseling. The person's ITP must specify the reasons the 
13.19 	provider must travel to the person.
13.20 	(j) Medical assistance covers medically necessary EIDBI services and consultations 
13.21 	delivered by a licensed health care provider via telemedicine, as defined under section 
13.22 	256B.0625, subdivision 3b, in the same manner as if the service or consultation was delivered 
13.23 	in person. Medical assistance coverage is limited to three telemedicine services per person 
13.24 	per calendar week.
13.25 		Subd. 14.Person's rights. A person or the person's legal representative has the right to:
13.26 	(1) protection as defined under the health care bill of rights under section 144.651;
13.27 	(2) designate an advocate to be present in all aspects of the person's and person's family's 
13.28 	services at the request of the person or the person's legal representative;
13.29 	(3) be informed of the agency policy on assigning staff to a person;
13.30 	(4) be informed of the opportunity to observe the person while receiving services;
13.31 	(5) be informed of services in a manner that respects and takes into consideration the 
13.32 	person's and the person's legal representative's culture, values, and preferences in accordance 
13.33 	with subdivision 3a;
14.1 	(6) be free from seclusion and restraint, except for emergency use of manual restraint 
14.2 	in emergencies as defined in section 245D.02, subdivision 8a;
14.3 	(7) be under the supervision of a responsible adult at all times;
14.4 	(8) be notified by the agency within 24 hours if an incident occurs or the person is injured 
14.5 	while receiving services, including what occurred and how agency staff responded to the 
14.6 	incident;
14.7 	(9) request a voluntary coordinated care conference; and
14.8 	(10) request a CMDE provider of the person's or the person's legal representative's 
14.9 	choice.
14.10 		Subd. 15.EIDBI provider qualifications. (a) A QSP must be employed by an agency 
14.11 	and be:
14.12 	(1) a licensed mental health professional who has at least 2,000 hours of supervised 
14.13 	clinical experience or training in examining or treating people with ASD or a related condition 
14.14 	or equivalent documented coursework at the graduate level by an accredited university in 
14.15 	ASD diagnostics, ASD developmental and behavioral treatment strategies, and typical child 
14.16 	development; or
14.17 	(2) a developmental or behavioral pediatrician who has at least 2,000 hours of supervised 
14.18 	clinical experience or training in examining or treating people with ASD or a related condition 
14.19 	or equivalent documented coursework at the graduate level by an accredited university in 
14.20 	the areas of ASD diagnostics, ASD developmental and behavioral treatment strategies, and 
14.21 	typical child development.
14.22 	(b) A level I treatment provider must be employed by an agency and:
14.23 	(1) have at least 2,000 hours of supervised clinical experience or training in examining 
14.24 	or treating people with ASD or a related condition or equivalent documented coursework 
14.25 	at the graduate level by an accredited university in ASD diagnostics, ASD developmental 
14.26 	and behavioral treatment strategies, and typical child development or an equivalent 
14.27 	combination of documented coursework or hours of experience; and
14.28 	(2) have or be at least one of the following:
14.29 	(i) a master's degree in behavioral health or child development or related fields including, 
14.30 	but not limited to, mental health, special education, social work, psychology, speech 
14.31 	pathology, or occupational therapy from an accredited college or university;
15.1 	(ii) a bachelor's degree in a behavioral health, child development, or related field 
15.2 	including, but not limited to, mental health, special education, social work, psychology, 
15.3 	speech pathology, or occupational therapy, from an accredited college or university, and 
15.4 	advanced certification in a treatment modality recognized by the department; or
15.5 	(iii) a board-certified assistant behavior analyst with 4,000 hours of supervised clinical 
15.6 	experience that meets all registration, supervision, and continuing education requirements 
15.7 	of the certification.
15.8 	(c) A level II treatment provider must be employed by an agency and must be:
15.9 	(1) a person who has a bachelor's degree from an accredited college or university in a 
15.10 	behavioral or child development science or related field including, but not limited to, mental 
15.11 	health, special education, social work, psychology, speech pathology, or occupational 
15.12 	therapy; and meet at least one of the following:
15.13 	(i) has at least 1,000 hours of supervised clinical experience or training in examining or 
15.14 	treating people with ASD or a related condition or equivalent documented coursework at 
15.15 	the graduate level by an accredited university in ASD diagnostics, ASD developmental and 
15.16 	behavioral treatment strategies, and typical child development or a combination of 
15.17 	coursework or hours of experience;
15.18 	(ii) certification as a board-certified assistant behavior analyst from the Behavior Analyst 
15.19 	Certification Board;
15.20 	(iii) is a registered behavior technician as defined by the Behavior Analyst Certification 
15.21 	Board; or
15.22 	(iv) is certified in one of the other treatment modalities recognized by the department; 
15.23 	or
15.24 	(2) a person who has:
15.25 	(i) an associate's degree in a behavioral or child development science or related field 
15.26 	including, but not limited to, mental health, special education, social work, psychology, 
15.27 	speech pathology, or occupational therapy from an accredited college or university; and
15.28 	(ii) at least 2,000 hours of supervised clinical experience in delivering treatment to people 
15.29 	with ASD or a related condition. Hours worked as a mental health behavioral aide or level 
15.30 	III treatment provider may be included in the required hours of experience; or
15.31 	(3) a person who has at least 4,000 hours of supervised clinical experience in delivering 
15.32 	treatment to people with ASD or a related condition. Hours worked as a mental health 
16.1 	behavioral aide or level III treatment provider may be included in the required hours of 
16.2 	experience; or
16.3 	(4) a person who is a graduate student in a behavioral science, child development science, 
16.4 	or related field and is receiving clinical supervision by a QSP affiliated with an agency to 
16.5 	meet the clinical training requirements for experience and training with people with ASD 
16.6 	or a related condition; or
16.7 	(5) a person who is at least 18 years of age and who:
16.8 	(i) is fluent in a non-English language;
16.9 	(ii) completed the level III EIDBI training requirements; and
16.10 	(iii) receives observation and direction from a QSP or level I treatment provider at least 
16.11 	once a week until the person meets 1,000 hours of supervised clinical experience.
16.12 	(d) A level III treatment provider must be employed by an agency, have completed the 
16.13 	level III training requirement, be at least 18 years of age, and have at least one of the 
16.14 	following:
16.15 	(1) a high school diploma or general equivalency diploma (GED);
16.16 	(2) fluency in a non-English language; or
16.17 	(3) one year of experience as a primary personal care assistant, community health worker, 
16.18 	waiver service provider, or special education assistant to a person with ASD or a related 
16.19 	condition within the previous five years.
16.20 		Subd. 16.Agency duties. (a) An agency delivering an EIDBI service under this section 
16.21 	must:
16.22 	(1) enroll as a medical assistance Minnesota health care program provider according to 
16.23 	Minnesota Rules, part 9505.0195, and section 256B.04, subdivision 21, and meet all 
16.24 	applicable provider standards and requirements;
16.25 	(2) demonstrate compliance with federal and state laws for EIDBI service;
16.26 	(3) verify and maintain records of a service provided to the person or the person's legal 
16.27 	representative as required under Minnesota Rules, parts 9505.2175 and 9505.2197;
16.28 	(4) demonstrate that while enrolled or seeking enrollment as a Minnesota health care 
16.29 	program provider the agency did not have a lead agency contract or provider agreement 
16.30 	discontinued because of a conviction of fraud; or did not have an owner, board member, or 
16.31 	manager fail a state or federal criminal background check or appear on the list of excluded 
17.1 	individuals or entities maintained by the federal Department of Human Services Office of 
17.2 	Inspector General;
17.3 	(5) have established business practices including written policies and procedures, internal 
17.4 	controls, and a system that demonstrates the organization's ability to deliver quality EIDBI 
17.5 	services;
17.6 	(6) have an office located in Minnesota;
17.7 	(7) conduct a criminal background check on an individual who has direct contact with 
17.8 	the person or the person's legal representative;
17.9 	(8) report maltreatment according to sections 626.556 and 626.557;
17.10 	(9) comply with any data requests consistent with the Minnesota Government Data 
17.11 	Practices Act, sections 256B.064 and 256B.27;
17.12 	(10) provide training for all agency staff on the requirements and responsibilities listed 
17.13 	in the Maltreatment of Minors Act, section 626.556, and the Vulnerable Adult Protection 
17.14 	Act, section 626.557, including mandated and voluntary reporting, nonretaliation, and the 
17.15 	agency's policy for all staff on how to report suspected abuse and neglect;
17.16 	(11) have a written policy to resolve issues collaboratively with the person and the 
17.17 	person's legal representative when possible. The policy must include a timeline for when 
17.18 	the person and the person's legal representative will be notified about issues that arise in 
17.19 	the provision of services;
17.20 	(12) provide the person's legal representative with prompt notification if the person is 
17.21 	injured while being served by the agency. An incident report must be completed by the 
17.22 	agency staff member in charge of the person. A copy of all incident and injury reports must 
17.23 	remain on file at the agency for at least five years from the report of the incident; and
17.24 	(13) before starting a service, provide the person or the person's legal representative a 
17.25 	description of the treatment modality that the person shall receive, including the staffing 
17.26 	certification levels and training of the staff who shall provide a treatment.
17.27 	(b) When delivering the ITP, and annually thereafter, an agency must provide the person 
17.28 	or the person's legal representative with:
17.29 	(1) a written copy and a verbal explanation of the person's or person's legal 
17.30 	representative's rights and the agency's responsibilities;
18.1 	(2) document in the person's file the date that the person or the person's legal 
18.2 	representative received a copy and explanation of the person's or person's legal 
18.3 	representative's rights and the agency's responsibilities; and
18.4 	(3) reasonable accommodations to provide the information in another format or language 
18.5 	as needed to facilitate understanding of the person's or person's legal representative's rights 
18.6 	and the agency's responsibilities.
18.7 		Subd. 17.Provider shortage; authority for exceptions. (a) In consultation with the 
18.8 	Early Intensive Developmental and Behavioral Intervention Advisory Council and 
18.9 	stakeholders, including agencies, professionals, parents of people with ASD or a related 
18.10 	condition, and advocacy organizations, the commissioner shall determine if a shortage of 
18.11 	EIDBI providers exists. For the purposes of this subdivision, "shortage of EIDBI providers" 
18.12 	means a lack of availability of providers who meet the EIDBI provider qualification 
18.13 	requirements under subdivision 15 that results in the delay of access to timely services under 
18.14 	this section, or that significantly impairs the ability of a provider agency to have sufficient 
18.15 	providers to meet the requirements of this section. The commissioner shall consider 
18.16 	geographic factors when determining the prevalence of a shortage. The commissioner may 
18.17 	determine that a shortage exists only in a specific region of the state, multiple regions of 
18.18 	the state, or statewide. The commissioner shall also consider the availability of various types 
18.19 	of treatment modalities covered under this section.
18.20 	(b) The commissioner, in consultation with the Early Intensive Developmental and 
18.21 	Behavioral Intervention Advisory Council and stakeholders, must establish processes and 
18.22 	criteria for granting an exception under this paragraph. The commissioner may grant an 
18.23 	exception only if the exception would not compromise a person's safety and not diminish 
18.24 	the quality and effectiveness of the treatment. The commissioner may grant an exception 
18.25 	for the following:
18.26 	(1) EIDBI provider qualifications under this section;
18.27 	(2) medical assistance provider enrollment requirements under section 256B.04, 
18.28 	subdivision 21; or
18.29 	(3) EIDBI provider or agency standards or requirements.
18.30 	(c) If the commissioner, in consultation with the Early Intensive Developmental and 
18.31 	Behavioral Intervention Advisory Council and stakeholders, determines that a shortage no 
18.32 	longer exists, the commissioner must submit a notice that a shortage no longer exists to the 
18.33 	chairs and ranking minority members of the senate and the house of representatives 
18.34 	committees with jurisdiction over health and human services. The commissioner must post 
19.1 	the notice for public comment for 30 days. The commissioner shall consider all public 
19.2 	comments before the commissioner makes a final determination regarding the termination 
19.3 	and timeline for termination of an exception granted under this subdivision. Until the shortage 
19.4 	ends, the commissioner shall annually provide an update on the status of the provider 
19.5 	shortage and exception process to the chairs and ranking minority members of the senate 
19.6 	and house of representatives committees with jurisdiction over health and human services.

19.7 	EFFECTIVE DATE. Subdivisions 15 and 17 are effective the day following final 
19.8 	enactment. Subdivisions 1 to 9, 13, 14, and 16 are effective July 1, 2017.